Artemis Medicare Services Ltd

Artemis Medicare Services Ltd has submitted its Monitoring Agency Report for the quarter ended June 30, 2026, prepared by CARE Ratings Limited. The report, in relation to a Preferential Issue of ₹330 crore, confirms no deviation from the objects of the issue. The report has been reviewed by the company's Audit Committee and is available on the company's investor website. CARE Ratings Limited acts as the Monitoring Agency as per SEBI regulations and the Monitoring Agency Agreement dated April 03, 2024.

Artemis Medicare Services Ltd reported its financial results for the quarter ended June 30, 2026. Consolidated revenue from operations increased by 12.7% year-on-year to Rs 28,732 Lacs. EBITDA saw a significant rise of 27.9% to Rs 6,182 Lacs, and Profit After Tax (PAT) surged by 48.3% to Rs 3,144 Lacs. The company also highlighted the commencement of operations at its Raipur hospital in July 2026, marking a strategic expansion. Performance highlights for Artemis Hospital Gurgaon also showed strong YoY growth in revenue, EBITDA, and PAT, along with improved bed capacity utilization and ARPOB. The company expressed confidence in its business model and future growth prospects.

Artemis Medicare Services Ltd. announced a significant capacity expansion plan for its flagship hospital in Gurugram. The company's Board of Directors has approved the addition of over 200 beds through the development of Tower IV. This expansion aims to enhance the hospital's service offerings and accommodate a larger patient base. The board also approved the un-audited financial results for the quarter ended June 30, 2026. The company will publish these results on stock exchange websites and its own website, adhering to SEBI Listing Regulations.

Artemis Medicare Services Ltd. announced its un-audited financial results for the quarter ended June 30, 2026. The results, which include both standalone and consolidated figures, were approved by the Board of Directors. The company also disclosed an expansion plan for Tower IV at its flagship hospital in Gurugram. The full financial results will be available on the websites of the stock exchanges and the company.

Artemis Medicare's consolidated Q1 FY27 (quarter ended June 30, 2026) print is a clean beat on both lines and on margin trajectory. Consolidated revenue rose 12.7% YoY to ₹287.32 Cr (up 2.9% QoQ from ₹279.23 Cr), while consolidated PAT jumped 48.3% YoY to ₹31.44 Cr (+3.8% QoQ from ₹30.28 Cr) — with no exceptional items in either the current or year-ago quarter, so the reported and adjusted growth numbers are identical. Standalone tells a very similar story: PAT of ₹31.05 Cr, up ~45.0% YoY, a divergence of roughly 3 points from the consolidated pace, explained by the Cardiac Care subsidiary's incremental contribution rather than any accounting distortion. The entire beat sits on the margin line. Consolidated OPM (EBITDA/revenue, computed as revenue less operative, employee and other expenses) expanded to 19.6% from 16.2% a year ago and 18.5% last quarter; NPM improved to 10.7% from 8.1% YoY. That is notable against management's own May 2026 guidance, which had flagged a temporary 1–1.5% consolidated EBITDA margin drag and an initial ₹18–20 Cr loss from the new Raipur facility ramping up in Q1 FY27 — none of that drag shows up in this quarter's numbers; margins moved the opposite way. One caveat: the Raipur hospital (Artemis Shanti) was formally launched only on July 9, 2026, after this quarter's June 30 close, even though Annexure A already counts ~300 Raipur beds as existing capacity — so the guided margin hit may simply not have hit the P&L yet rather than having been avoided. Management had separately guided the flagship Gurugram hospital to grow revenue 15–17%; the filing gives no city/hospital-level revenue split, so that specific claim can't be directly verified, and total consolidated revenue growth of 12.7% runs below that band regardless. We found no Q1 FY27-specific street estimates for revenue or PAT in a search of brokerage previews — coverage exists (an Anand Rathi-hosted call is set for August 4, and full-year FY26-27 consensus points to ~30.6% earnings and ~20.3% revenue CAGR per Simply Wall St) but no pre-print quarterly number, so vsStreet is unknown rather than assumed. No separate management press release was available in the context to cross-check framing. The same board meeting also approved a Tower IV expansion at the Gurugram flagship — 200+ beds for quaternary pediatric and advanced gynecology/women's health care, ~₹160–180 Cr over ~2 years funded via internal accruals and debt — consistent with the previously guided 800-to-2,000+ bed roadmap through FY29. Gurugram flagship utilization stood at 65.7% in Q1 FY27, the base management is expanding against. Going into Q2 FY27, the two things to watch are whether the Raipur margin drag guided for this quarter shows up next quarter instead, and whether Tower IV capex execution and funding mix (accruals vs. debt) tracks the ₹160–180 Cr, ~2-year plan.

Artemis Medicare Services Ltd has announced that Mr. Sanjib Sen has ceased to be an Independent Director of the company on August 2, 2026, upon completion of his tenure. This intimation is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has provided the necessary details as required by the SEBI Listing Regulations in an annexure to the filing. This change marks the end of Mr. Sen's service as an independent director.

Artemis Medicare Services Ltd announced the re-appointment of M/s. T R Chadha & Co LLP as Statutory Auditors for a second term of five years. The approval was granted by the company's members at the 22nd Annual General Meeting (AGM) held on July 31, 2026. The auditors will serve from the conclusion of the 22nd AGM until the conclusion of the 27th AGM in 2031. T R Chadha & Co LLP is a well-established Chartered Accountancy firm with over 80 years of experience, comprising 24 partners and over 1000 staff across 11 Indian cities.

Artemis Medicare Services Ltd announced the appointment of Dr. Girdhar Jessaram Gyani as an Independent Director for a term of three years, effective August 1, 2026. The appointment was approved by the company's members at the 22nd Annual General Meeting held on July 31, 2026. Dr. Gyani brings extensive experience in the healthcare industry, having served as Director General of the Association of Healthcare Providers (India) and previously as Secretary General of the Quality Council of India. He was instrumental in establishing the National Accreditation Board for Hospitals (NABH). Dr. Gyani has no disclosed relationship with any other director of the company and is not debarred from holding a director's office.

Artemis Medicare Services Ltd has announced that its Board of Directors will convene on August 3, 2026, to consider and approve the un-audited financial results for the quarter ending June 30, 2026. The results will be both standalone and consolidated. The company also confirmed that the trading window, which closed on July 1, 2026, will remain shut until 48 hours after the declaration of these financial results, extending up to August 5, 2026.

Artemis Medicare Services Ltd has announced the commencement of operations for its new Artemis Shanti Hospital in Raipur, Chhattisgarh, effective July 9, 2026. This 300-bed multi-specialty tertiary care hospital aims to provide advanced medical expertise and world-class infrastructure to the region. The launch is part of Artemis's expansion strategy to increase access to quality healthcare in high-growth markets across India. The hospital will offer comprehensive services in specialties like cardiology, oncology, neurosciences, and orthopaedics, equipped with state-of-the-art facilities to reduce the need for patients to travel to metro cities for complex treatments.